Global Intravenous (IV) Solutions Market, By Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Solution (Saline, Dextran, Lactated Ringer’s, Amino Acid, Vitamins and Minerals, Heparin and Trace Elements, Mixed Solutions), Bag Type (Large Volume Bags, Small Volume Bags), Demographic (Adult, Pediatric, Geriatric), Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, Irrigation IV Solution, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Intravenous (IV) Solutions Market
Intravenous (IV) solutions market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.30% in the above mentioned forecast period.
Water, electrolytes, sugar, and pharmaceuticals are all included in intravenous (IV) solutions. To restore fluid volume and manage electrolyte balance, they are administered to patients based on their needs, medical condition, age, and body size. They are also commonly used in IV therapy to replenish electrolytes, give medicines and blood products, and provide vital nutrients to the intravascular fluid compartment.
The rise in the prevalence of gastrointestinal disorder and neurological diseases because of unhealthy eating habits act as a major factor driving the market’s growth rate. Additionally, rising healthcare expenditure is the market driver influencing the growth rate of intravenous (IV) solutions market. Furthermore, increasing incidences of infection and rise in the acceptance of vitamin C intravenous solutions for colorectal cancer are the factors that will expand the intravenous (IV) solutions market. Other factors including rise in the growing government initiatives and rising awareness will positively impact the market growth rate. Another significant factor that will cushion the growth of intravenous (IV) solutions market is the increase in number of cases of cancer and diabetes. Also, rise in the level of disposable income and increase in sedentary lifestyle will escalate the market growth rate for the mention forecast period mentioned above. The demand for IV therapy to provide anesthetic, pain medicines, antibiotics, fluids, and other important fluids in patients requiring critical care is increasing and hence increase the need for intravenous (IV) solutions market.
Moreover, the rise in the research and development activities and increasing product launches will provide beneficial opportunities for the intravenous (IV) solutions market in the forecast period of 2022-2029. Additionally, emerging new market and the improving healthcare infrastructure will act as major markets drivers that will create new opportunities for the markets growth rate.
However, high cost associated with product will impede the market’s growth rate. Also, the increasing number of technical norms and strict policies by regulatory authorities will hamper the intravenous (IV) solutions market’s growth. Lack of awareness will further challenge the intravenous (IV) solutions market in the forecast period mentioned above.
This intravenous (IV) solutions market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intravenous (IV) solutions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Intravenous (IV) Solutions Market Scope and Market Size
The intravenous (IV) solutions market is segmented on the basis of type, solution, demographic, bag type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the intravenous (IV) solutions market is segmented into partial parenteral nutrition and total parenteral nutrition.
- On the basis of solution, the intravenous (IV) solutions market is segmented into saline, dextran, lactated ringer’s, amino acid, vitamins and minerals, heparin and trace elements, and mixed solutions. The saline segment is further sub-segmented into normal saline and hypertonic saline.
- On the basis of demographic, the intravenous (IV) solutions market is segmented into adult, pediatric and geriatric.
- On the basis of bag type, the intravenous (IV) solutions market is segmented into large volume bags and small volume bags
- On the basis of application, the intravenous (IV) solutions market is segmented into basic IV solution, nutritional IV solution, blood IV solution, drug IV solution, irrigation IV solution and others.
- On the basis of end-users, the intravenous (IV) solutions market is segmented into clinic, hospital and others.
The intravenous (IV) solutions market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Intravenous (IV) Solutions Market Country Level Analysis
Intravenous (IV) solutions market is analyzed and market size information is provided by the country, type, solution, demographic, bag type, application, end-users and distribution channel as referenced above.
The countries covered in the intravenous (IV) solutions market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the intravenous (IV) solutions market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and rising government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Intravenous (IV) solutions market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Intravenous (IV) Solutions Market Share Analysis
Intravenous (IV) solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to intravenous (IV) solutions market research.
Some of the major players operating in the intravenous (IV) solutions market are Fresenius SE & Co. KGaA, B. Braun Melsungen AG, ICU Medical, Inc., Pfizer Inc., Grifols, S.A., Baxter, Terumo Medical Corporation, Ajinomoto Co., Inc., Otsuka America Pharmaceutical, Inc., Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, Axa Parenterals Ltd., and Salius Pharma Private Limited., among others.
SKU-
